a month ago
LLY
AnalystsAlexandria HammondAlexandria Hammond's Stock Forecasts
AnalystsAlexandria Hammond
Sectors:
Industries:
Analyst Ranking
Top 32%
#1649 out of 5290 analysts
Average Return
+14.62%
Win Rate
64%9 out of 14
Risk vs Reward
Poor
Good
Alexandria Hammond's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +63.08% | $9.10 | $14.84 | 2025-08-24 - 2025-10-30 | Strong Buy |
Gilead Sciences IncGILD | +41.43% | $88.40 | $125.02 | 2024-11-14 - 2025-11-14 | Buy |
Abbvie IncABBV | +40.83% | $164.99 | $232.36 | 2024-11-14 - 2025-11-14 | Buy |
Eli Lilly & CoLLY | +37.40% | $746.20 | $1,025.28 | 2024-11-14 - 2025-11-14 | Buy |
Moderna IncMRNA | +32.78% | $36.85 | $24.77 | 2024-11-14 - 2025-11-14 | Sell |
Alexandria Hammond Analyst Color
Get additional color on Alexandria Hammond's coverage of popular stocks
5 months ago
MRK
2 years ago
PFE
2 years ago
LLY
Alexandria Hammond's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Eli Lilly & CoLLY | 2 | Buy | $1,325.00 | +17.75% | Reiterates | a month ago |
Madrigal Pharmaceuticals IncMDGL | 3 | Hold | $529.00 | +7.34% | Maintains | 4 months ago |
Merck & Co IncMRK | 1 | Buy | $135.00 | +12.26% | Upgrades | 5 months ago |
89bio IncETNB | 2 | Strong Buy | $29.00 | +95.42% | Maintains | 9 months ago |
Akero Therapeutics IncAKRO | 4 | Strong Buy | $64.00 | N/A | Maintains | a year ago |
Regeneron Pharmaceuticals IncREGN | 1 | Buy | $1,150.00 | N/A | Initiates Coverage On | 2 years ago |
Pfizer IncPFE | 1 | Sell | $25.00 | N/A | Initiates Coverage On | 2 years ago |
Moderna IncMRNA | 1 | Sell | $40.00 | N/A | Initiates Coverage On | 2 years ago |
Johnson & JohnsonJNJ | 1 | Buy | $190.00 | N/A | Initiates Coverage On | 2 years ago |
Gilead Sciences IncGILD | 1 | Buy | $110.00 | N/A | Initiates Coverage On | 2 years ago |
Abbvie IncABBV | 1 | Buy | $205.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.